To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MUM1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
380 supporting clones for gene MUM1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_44170628   .a 1 to 810 86 to 906       826/907
(91 %)
30 diff
(96.7 %id)
BG701801 brain, hippocampus .a 3 to 714 1 to 711       711/711
(100 %)
9 diff
(98.8 %id)
BI553935 brain, hippocampus .a 3 to 810 1 to 819   tiling clone,   819/820
(99 %)
26 diff
(96.9 %id)
DB636426 hippocampus .a 12 to 677 1 to 664       664/668
(99 %)
11 diff
(98.4 %id)
CN430688 embryonic stem cells, cell lines H1, H7, andH9 .a 24 to 698 1 to 675       675/675
(100 %)
4 diff
(99.5 %id)
BQ895780 carcinoma, cell line, Prostate .a 45 to 954 15 to 927   tiling clone,   913/927
(98 %)
20 diff
(97.9 %id)
BQ895767 carcinoma, cell line, Prostate .a 45 to 831 22 to 814   AAA   793/920
(86 %)
34 diff
(96.4 %id)
BQ945443 carcinoma, cell line, Prostate .a 45 to 873 34 to 880       847/980
(86 %)
35 diff
(96.5 %id)
BM047171 carcinoma, cell line, Prostate .a 48 to 901 1 to 856       856/862
(99 %)
41 diff
(95.3 %id)
BM047900 carcinoma, cell line, Prostate .a 49 to 849 1 to 809       809/811
(99 %)
33 diff
(96.0 %id)
BM047244 carcinoma, cell line, Prostate .a 49 to 799 1 to 759       761/760
(100 %)
25 diff
(96.8 %id)
BQ919253 carcinoma, cell line, Prostate .a 51 to 920 1 to 876       876/958
(91 %)
16 diff
(98.4 %id)
BQ936799 carcinoma, cell line, Prostate .a 51 to 831 1 to 787       787/988
(79 %)
12 diff
(98.8 %id)
BQ958626 carcinoma, cell line, Prostate .a 51 to 927 1 to 889       889/916
(97 %)
23 diff
(97.5 %id)
BU541563 carcinoma, cell line, Prostate .a 51 to 885 1 to 842   tiling clone,   842/900
(93 %)
11 diff
(98.8 %id)
BQ957298 carcinoma, cell line, Prostate .a 75 to 942 50 to 930       881/982
(89 %)
41 diff
(95.9 %id)
CR982979 T-Lymphocytes .a 85 to 789 1 to 705       705/705
(100 %)
3 diff
(99.6 %id)
AI138869   .a 90 to 587 1 to 498     Submitted on the opposite strand 498/498
(100 %)
3 diff
(99.4 %id)
AI376784 pooled .a 90 to 408 1 to 319     Submitted on the opposite strand 319/319
(100 %)
1 diff
(99.7 %id)
BC144138 Brain, cerebellum, PCR rescued clones .a 174 to 3010 1 to 2837 G220R tiling clone,   2837/2837
(100 %)
3 diff
(99.9 %id)
TI_2194643683   .a 1327 to 2435 9 to 1117       1109/1319
(84 %)
20 diff
(98.5 %id)
TI_2194643692   .a 1706 to 2915 12 to 1229       1218/1293
(94 %)
50 diff
(96.2 %id)
TI_2194643253   .a 1875 to 3010 1206 to 73       1134/1252
(90 %)
27 diff
(97.9 %id)
TI_2194642953   .a 1896 to 3010 1193 to 72       1122/1210
(92 %)
42 diff
(96.6 %id)
TI_2194643243   .a 1929 to 3010 1150 to 70       1081/1290
(83 %)
36 diff
(97.3 %id)
TI_2194645925   .a 1960 to 3010 1118 to 74       1045/1232
(84 %)
10 diff
(99.2 %id)
TI_2194643675   .a 2115 to 3010 15 to 910       896/1286
(69 %)
8 diff
(99.4 %id)
AK310721 thymus .b 1 to 2599 5 to 2603 exact tiling clone,   2603/2603
(100 %)
2 diff
(100.0 %id)
DC410184 thymus .b 1 to 585 5 to 589       589/589
(100 %)
2 diff
(99.7 %id)
AA352613   .b 8 to 324 1 to 317       317/317
(100 %)
2 diff
(99.4 %id)
DR158298 human embryonic stem cells differentiated toan early endodermal cell type .b 9 to 743 1 to 735       735/735
(100 %)
1 diff
(99.9 %id)
CN430689 embryonic stem cells, cell lines H1, H7, andH9 .b 30 to 769 16 to 756   tiling clone,   741/756
(98 %)
7 diff
(99.1 %id)
DB528158 testis .b 2219 to 2654 1 to 436   tiling clone, Submitted on the opposite strand 436/436
(100 %)
8 diff
(98.2 %id)
BU603319 mixed (pool of 40 RNAs) .c 1 to 215 4 to 215   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 215/228
(94 %)
13 diff
(94.3 %id)
NM_032853.3   .c 1 to 4098 4 to 4101 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 4101/4101
(100 %)
0 diff
(100 %id)
DB286119 uterus .c 2 to 557 2 to 554   capped   553/553
(100 %)
5 diff
(99.1 %id)
DB286496 uterus .c 3 to 557 2 to 553   capped   552/552
(100 %)
5 diff
(99.1 %id)
DA107610 cerebellum .c 9 to 555 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA739708   .c 9 to 547 2 to 540   tiling clone, capped   539/541
(99 %)
1 diff
(99.9 %id)
DB198154 trachea .c 9 to 595 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA377439 thalamus .c 12 to 570 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB177947 kidney, tumor tissue .c 12 to 580 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA125469 cerebellum .c 13 to 590 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
BX955918   .c 14 to 493 1 to 480       480/480
(100 %)
3 diff
(99.4 %id)
DB073402 testis .c 15 to 541 2 to 528   capped   527/527
(100 %)
3 diff
(99.5 %id)
DA757234   .c 24 to 588 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
BC110874 Brain, anaplastic oligodendroglioma with1p/19q loss .c 32 to 2614 1 to 2583 G220R tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2583/2583
(100 %)
3 diff
(99.9 %id)
EC445961 Prostate .c 33 to 127 1 to 95       95/95
(100 %)
0 diff
(100 %id)
BG820635 anaplastic oligodendroglioma with 1p/19qloss, brain .c 34 to 778 2 to 741       742/746
(99 %)
23 diff
(97.0 %id)
U20897 melanoma .c 34 to 1343 8 to 1316       1309/1316
(99 %)
8 diff
(99.4 %id)
BQ716442 sympathetic trunk .c 35 to 769 1 to 738       738/924
(79 %)
9 diff
(99.1 %id)
CN430687 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 57 to 697 7 to 647       641/647
(99 %)
6 diff
(99.1 %id)
TI_2194642950   .c 81 to 1138 49 to 1112       1064/1199
(88 %)
26 diff
(97.9 %id)
TI_2194643247   .c 81 to 1191 47 to 1151     Submitted on the opposite strand 1105/1301
(84 %)
35 diff
(97.4 %id)
TI_2194643251   .c 81 to 1156 49 to 1113     Submitted on the opposite strand 1065/1278
(83 %)
40 diff
(96.9 %id)
TI_2194643753   .c 81 to 852 249 to 1018   AAA Submitted on the opposite strand 770/1128
(68 %)
30 diff
(97.4 %id)
TI_2194645544   .c 81 to 1135 47 to 1093       1047/1256
(83 %)
17 diff
(98.7 %id)
BE883047 leiomyosarcoma, uterus .c 97 to 852 1 to 759       761/912
(83 %)
33 diff
(96.4 %id)
CX788835 human embryonic stem cells .c 166 to 955 1 to 789       789/789
(100 %)
4 diff
(99.5 %id)
BF984952 duodenal adenocarcinoma, cell line, small intestine .c 167 to 866 27 to 724       698/991
(70 %)
17 diff
(98.3 %id)
BU187879 eye, retinoblastoma .c 214 to 1109 1 to 907       907/915
(99 %)
21 diff
(97.8 %id)
BF530855 anaplastic oligodendroglioma with 1p/19qloss, brain .c 218 to 931 730 to 23     Submitted on the opposite strand 708/936
(75 %)
7 diff
(99.3 %id)
DA194639 amygdala .c 261 to 864 2 to 605   capped   604/604
(100 %)
2 diff
(99.7 %id)
DA736368   .c 288 to 982 2 to 697   tiling clone, capped   696/696
(100 %)
6 diff
(99.2 %id)
DA227783 brain .c 335 to 870 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
TI_59382363   .c 389 to 1138 106 to 869       764/944
(80 %)
50 diff
(94.8 %id)
BM013115 brain, neuroblastoma, cell line .c 390 to 1138 1 to 763       763/943
(80 %)
50 diff
(94.7 %id)
DB063246 testis .c 428 to 978 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
BX280542 leiomyosarcoma, uterus .c 462 to 951 1 to 490       490/490
(100 %)
2 diff
(99.6 %id)
BM460746 leiomyosarcoma, uterus .c 465 to 1215 1 to 759       759/1124
(67 %)
12 diff
(99.0 %id)
BQ720834 sympathetic trunk .c 476 to 1388 1 to 921       921/939
(98 %)
28 diff
(97.1 %id)
DA309875 hippocampus .c 528 to 1078 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA105613 cerebellum .c 581 to 1181 2 to 602   capped   601/605
(99 %)
3 diff
(99.6 %id)
DA406276 thalamus .c 641 to 1195 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA758876   .c 650 to 1182 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BQ059551 lymph, lymphoma, cell line .c 660 to 1531 1 to 875       875/1033
(84 %)
18 diff
(98.3 %id)
TI_2194643678   .c 673 to 1855 1 to 1174       1174/1267
(92 %)
22 diff
(98.3 %id)
TI_2194643679   .c 673 to 1887 1 to 1212       1212/1287
(94 %)
30 diff
(97.7 %id)
BF802881 colon_ins .c 678 to 1009 18 to 345       328/347
(94 %)
11 diff
(96.9 %id)
DA416650 thalamus .c 723 to 1268 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA756926   .c 733 to 1235 2 to 504   capped   503/503
(100 %)
1 diff
(99.9 %id)
DA953159 Spleen .c 749 to 1301 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA953199 Spleen .c 749 to 1309 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA108837 cerebellum .c 752 to 1339 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
CN280419 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 857 to 1361 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
CN277240 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 882 to 1471 1 to 590       590/590
(100 %)
4 diff
(99.4 %id)
DA798900 brain .c 916 to 1461 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
CN280418 embryonic stem cells, DMSO-treated H9 cellline .c 950 to 1436 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
BQ071565 brain, neuroblastoma, cell line .c 956 to 1733 20 to 805       786/1136
(69 %)
20 diff
(98.3 %id)
BQ071619 brain, neuroblastoma, cell line .c 967 to 1864 1 to 907       907/1051
(86 %)
21 diff
(98.1 %id)
DB099316 testis .c 1034 to 1565 61 to 592   capped   532/591
(90 %)
6 diff
(99.0 %id)
DB099977 testis .c 1046 to 1629 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DN999676   .c 1132 to 1780 1 to 649       649/649
(100 %)
9 diff
(98.7 %id)
BP330442 rectum .c 1171 to 1763 1 to 594       594/594
(100 %)
4 diff
(99.4 %id)
DA933993 Spleen .c 1174 to 1751 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BG911922 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1198 to 1921 1 to 725       725/725
(100 %)
8 diff
(98.9 %id)
TI_2194643676   .c 1228 to 2370 1 to 1132       1132/1290
(87 %)
19 diff
(98.6 %id)
DA335319 hippocampus .c 1268 to 1847 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM697775 eye, fetal eyes .c 1282 to 1686 1 to 405     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 405/405
(100 %)
0 diff
(100 %id)
BF365592 nervous_tumor .c 1290 to 1603 330 to 16       315/331
(95 %)
3 diff
(99.1 %id)
D44937 brain .c 1302 to 1418 1 to 117       117/117
(100 %)
0 diff
(100 %id)
DA355032 subthalamic nucleus .c 1337 to 1872 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
AK075241 thyroid gland .c 1368 to 4095 1 to 2728   tiling clone, available from FLJ,   2728/2728
(100 %)
6 diff
(99.8 %id)
DB165866 thyroid gland .c 1369 to 2070 2 to 704   capped   703/703
(100 %)
13 diff
(98.2 %id)
DA031668   .c 1408 to 1992 2 to 590   capped   589/589
(100 %)
4 diff
(99.4 %id)
DA731329   .c 1494 to 2219 2 to 728   capped   727/727
(100 %)
3 diff
(99.6 %id)
CN337679 embryonic stem cells, cell lines H1, H7, andH9 .c 1503 to 1759 1 to 257       257/257
(100 %)
4 diff
(98.5 %id)
DA206973 brain .c 1510 to 2075 2 to 567   capped   566/567
(99 %)
1 diff
(99.9 %id)
BF527499 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1513 to 2246 1 to 728   available from MGC,   728/817
(89 %)
17 diff
(98.0 %id)
BC008098 Brain, anaplastic oligodendroglioma with1p/19q loss .c 1514 to 2620 1 to 1107   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1107/1107
(100 %)
1 diff
(100.0 %id)
BG750162 eye, normal pigmented retinal epithelium .c 1515 to 2032 1 to 528       528/904
(58 %)
20 diff
(97.8 %id)
AK027774 placenta .c 1529 to 2614 1 to 1086   available from FLJ,   1086/1086
(100 %)
3 diff
(99.8 %id)
DA829122 placenta .c 1530 to 2206 2 to 681   capped   680/734
(92 %)
6 diff
(99.2 %id)
BC082987 Peripheral Nervous System, dorsal rootganglion .c 1547 to 4095 1 to 2549   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 2549/2549
(100 %)
4 diff
(99.9 %id)
BQ888943 dorsal root ganglia .c 1548 to 2374 1 to 838       838/924
(90 %)
22 diff
(97.7 %id)
TI_2194643684   .c 1605 to 2760 1 to 1164       1164/1281
(90 %)
24 diff
(98.2 %id)
BQ109552 leukocyte .c 1649 to 2342 1 to 696       696/696
(100 %)
5 diff
(99.3 %id)
TI_2194643240   .c 1651 to 2762 1151 to 56       1096/1272
(86 %)
32 diff
(97.5 %id)
TI_2194643241   .c 1658 to 2762 1158 to 55       1104/1300
(84 %)
9 diff
(99.4 %id)
CX787670 human embryonic stem cells .c 1662 to 2477 1 to 816       816/816
(100 %)
7 diff
(99.2 %id)
TI_2016730225   .c 1670 to 2761 1137 to 57     Submitted on the opposite strand 1081/1217
(88 %)
11 diff
(99.1 %id)
DA302945 hippocampus .c 1681 to 2151 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DA298854 hippocampus .c 1708 to 2283 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
TI_2194642949   .c 1709 to 2762 1100 to 59     Submitted on the opposite strand 1042/1231
(84 %)
19 diff
(98.5 %id)
TI_2194645542   .c 1715 to 2762 1094 to 57     Submitted on the opposite strand 1038/1244
(83 %)
15 diff
(98.8 %id)
CN337677 embryonic stem cells, cell lines H1, H7, andH9 .c 1722 to 2275 1 to 554       554/556
(99 %)
3 diff
(99.5 %id)
CD557379 testis .c 1778 to 2388 22 to 637       616/883
(69 %)
13 diff
(98.6 %id)
EL733623 mixed .c 1785 to 2242 1 to 458       458/545
(84 %)
1 diff
(99.9 %id)
BF771296 epid_tumor .c 1791 to 2186 35 to 427       393/441
(89 %)
8 diff
(98.2 %id)
TI_1948238312   .c 1838 to 2242 1015 to 597     Submitted on the opposite strand 419/1280
(32 %)
30 diff
(97.7 %id)
AL709838 human skeletal muscle .c 1850 to 2423 1 to 571       571/571
(100 %)
5 diff
(99.2 %id)
CN337678 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1864 to 2610 1 to 748       748/748
(100 %)
2 diff
(99.8 %id)
BQ446026 Knee, Osteoarthritic Cartilage .c 1893 to 2620 743 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 728/728
(100 %)
1 diff
(99.9 %id)
BX088661 whole brain .c 1902 to 2444 1 to 541       541/541
(100 %)
5 diff
(99.1 %id)
R20457 whole brain .c 1903 to 2275 1 to 374       374/374
(100 %)
1 diff
(99.8 %id)
DA701750   .c 1905 to 2360 2 to 457   capped   456/456
(100 %)
1 diff
(99.8 %id)
AA428710 ovarian tumor, ovary .c 1916 to 2216 1 to 299   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 299/299
(100 %)
3 diff
(99.0 %id)
DB528823 hippocampus .c 1957 to 2621 1 to 665     Submitted on the opposite strand 665/665
(100 %)
2 diff
(99.7 %id)
BQ005836 Chondrosarcoma, Left Pubic Bone .c 1980 to 2617 652 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 637/637
(100 %)
2 diff
(99.7 %id)
AW379514 head_neck .c 2019 to 2389 12 to 380       369/388
(95 %)
7 diff
(98.2 %id)
TI_1607545459   .c 2021 to 2761 11 to 750       740/1333
(55 %)
8 diff
(99.4 %id)
TI_2194643688   .c 2026 to 2762 18 to 753       736/1312
(56 %)
8 diff
(99.4 %id)
BU736059 eye, fetal eyes .c 2034 to 2615 602 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 582/584
(99 %)
0 diff
(100 %id)
BU623021 cell lines, Chondrosarcoma .c 2041 to 2614 592 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 574/574
(100 %)
0 diff
(100 %id)
AF151045 umbilical cord blood .c 2063 to 2681 1 to 621   tiling clone,   621/621
(100 %)
4 diff
(99.4 %id)
AA573130 adrenal adenoma, adrenal gland .c 2063 to 2621 559 to 1       559/559
(100 %)
3 diff
(99.5 %id)
BM147959 leukopheresis .c 2068 to 2519 1 to 452       452/452
(100 %)
16 diff
(96.5 %id)
AA428278 ovarian tumor, ovary .c 2171 to 2617 460 to 14   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 447/447
(100 %)
1 diff
(99.8 %id)
AA909294 pooled .c 2180 to 2619 444 to 2       443/450
(98 %)
0 diff
(100 %id)
BE909605 epithelioid carcinoma, Pancreas .c 2180 to 2577 5 to 402       398/402
(99 %)
6 diff
(98.6 %id)
AW196582 pooled germ cell tumors .c 2185 to 2619 439 to 5       435/443
(98 %)
0 diff
(100 %id)
DB373822 placenta .c 2234 to 2614 381 to 1       381/384
(99 %)
10 diff
(97.4 %id)
DB363468   .c 3525 to 4098 571 to 1       571/576
(99 %)
18 diff
(96.9 %id)
DB368834   .c 3557 to 4100 538 to 1   tiling clone,   538/585
(91 %)
20 diff
(96.6 %id)
DB381699 thyroid gland .c 3643 to 4095 456 to 1       456/460
(99 %)
4 diff
(99.2 %id)
NR_024247.1   .d 1 to 4170 1 to 4170 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 4170/4170
(100 %)
0 diff
(100 %id)
TI_2194642952   .d 40 to 1132 66 to 1156     Submitted on the opposite strand 1091/1262
(86 %)
43 diff
(96.6 %id)
TI_2194643244   .d 40 to 1130 63 to 1151     Submitted on the opposite strand 1089/1330
(81 %)
32 diff
(97.6 %id)
TI_2194643248   .d 40 to 1155 65 to 1180     Submitted on the opposite strand 1116/1315
(84 %)
43 diff
(96.8 %id)
TI_2194645923   .d 40 to 1120 62 to 1130     Submitted on the opposite strand 1069/1269
(84 %)
26 diff
(98.0 %id)
TI_1607544611   .d 40 to 1117 65 to 1139     Submitted on the opposite strand 1075/1184
(90 %)
30 diff
(97.5 %id)
TI_1607545019   .d 40 to 1089 64 to 1106     Submitted on the opposite strand 1043/1293
(80 %)
36 diff
(97.3 %id)
BC130443 Brain, cerebellum, PCR rescued clones .d 41 to 2833 1 to 2793 G151R     2793/2793
(100 %)
3 diff
(99.9 %id)
BC144147 Brain, cerebellum, PCR rescued clones .d 41 to 2833 1 to 2793 G151R     2793/2793
(100 %)
3 diff
(99.9 %id)
DC335695 hippocampus .d 182 to 757 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
AK309092 hippocampus .e 1 to 2258 1 to 2258 R626G I627V tiling clone,   2258/2259
(99 %)
8 diff
(99.7 %id)
CA427121 Bone, Subchondral Bone .e 2237 to 2879 660 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 642/670
(95 %)
3 diff
(99.6 %id)
DB512556 testis .e 2259 to 2645 387 to 1       387/387
(100 %)
1 diff
(99.8 %id)
DA165292 amygdala .e 2414 to 2981 2 to 569   capped   568/568
(100 %)
5 diff
(99.2 %id)
DB119114 thymus .e 2463 to 2725 2 to 264   capped   263/263
(100 %)
1 diff
(99.7 %id)
N31319 melanocyte .e 2471 to 2946 1 to 478       478/478
(100 %)
4 diff
(99.2 %id)
AI688866 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 2501 to 2884 387 to 4       384/387
(99 %)
0 diff
(100 %id)
AI587412 adenocarcinoma, Pancreas .e 2515 to 2884 371 to 2       370/371
(99 %)
0 diff
(100 %id)
CR457395   .e 2566 to 3020 1 to 455       455/459
(99 %)
2 diff
(99.6 %id)
BQ722028 sympathetic trunk .e 2573 to 3165 1 to 592       592/949
(62 %)
17 diff
(98.3 %id)
BM823773 Ascites, stomach .e 2575 to 3042 1 to 468   tiling clone,   468/468
(100 %)
0 diff
(100 %id)
AI470084 pooled .e 2582 to 2884 307 to 5       303/307
(98 %)
0 diff
(100 %id)
H42878 breast .e 2586 to 2872 304 to 18       287/304
(94 %)
7 diff
(97.7 %id)
AI354873 esophagus, squamous cell carcinoma .e 2593 to 2882 307 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 289/289
(100 %)
2 diff
(99.4 %id)
DN997402 breast cancer, Mammary gland (cancer tissue) .e 2593 to 3167 8 to 583       576/583
(98 %)
6 diff
(99.0 %id)
BF341439 brain, glioblastoma with EGFR amplification .e 2657 to 3398 1 to 728       728/732
(99 %)
35 diff
(95.3 %id)
BM720961 eye, fetal eye .e 2662 to 3314 1 to 654     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BM810198 amelanotic melanoma, cell line, skin .e 2671 to 3547 27 to 906       880/1193
(73 %)
35 diff
(97.1 %id)
BM767144 stomach .e 2671 to 2879 1 to 209   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 209/209
(100 %)
0 diff
(100 %id)
BQ939678 epidermoid carcinoma, cell line, lung .e 2685 to 3516 1 to 848   tiling clone,   848/921
(92 %)
31 diff
(96.7 %id)
BI037949 nervous_tumor .e 2703 to 3065 16 to 379       364/379
(96 %)
6 diff
(98.5 %id)
C17502 placenta .e 2710 to 3067 1 to 356       356/356
(100 %)
4 diff
(98.9 %id)
BP305258   .e 2758 to 3334 1 to 577       577/580
(99 %)
28 diff
(95.2 %id)
DB494189.
matches multiple genes
hypothalamus .e 2763 to 3248 1 to 486     also hits gene tirori 486/486
(100 %)
5 diff
(99.0 %id)
AK025936   .e 2788 to 4361 1 to 1574   available from FLJ, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1574/1574
(100 %)
4 diff
(99.8 %id)
BP253445 Kidney .e 2788 to 3368 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
D81984 brain .e 2795 to 3139 1 to 344       344/344
(100 %)
5 diff
(98.6 %id)
BM472115 embryonal carcinoma, cell line, testis .e 2858 to 3545 1 to 692       692/1081
(64 %)
19 diff
(98.3 %id)
BM724313 eye, fetal eye .e 2863 to 3512 1 to 649     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 649/649
(100 %)
3 diff
(99.6 %id)
BP302396   .e 2867 to 3446 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BF827328 head_normal .e 2879 to 3090 15 to 225       211/227
(92 %)
6 diff
(97.4 %id)
AW953486   .e 2882 to 3584 11 to 713       703/714
(98 %)
9 diff
(98.8 %id)
R35196 whole brain .e 2883 to 3323 1 to 448     Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 448/516
(86 %)
24 diff
(95.4 %id)
CN337676 embryonic stem cells, cell lines H1, H7, andH9 .e 2926 to 3397 21 to 492       472/492
(95 %)
6 diff
(98.8 %id)
CB154971 brain .e 2946 to 3442 1 to 497       497/497
(100 %)
7 diff
(98.6 %id)
TI_57217498   .e 3042 to 3803 25 to 785       761/785
(96 %)
6 diff
(99.3 %id)
BF314588 brain, neuroblastoma .e 3044 to 3774 1 to 763       763/793
(96 %)
56 diff
(93.0 %id)
BF206568 brain, neuroblastoma .e 3045 to 3773 1 to 720       720/934
(77 %)
28 diff
(97.1 %id)
BF315246 brain, neuroblastoma .e 3045 to 3797 1 to 738       738/959
(76 %)
28 diff
(97.1 %id)
BI196038 brain, neuroblastoma .e 3045 to 3853 1 to 806       806/812
(99 %)
17 diff
(98.0 %id)
BI198922 brain, neuroblastoma .e 3045 to 4020 1 to 963       963/991
(97 %)
45 diff
(95.5 %id)
BI754229 brain .e 3045 to 3803 1 to 758       758/758
(100 %)
3 diff
(99.7 %id)
BI196122 brain, neuroblastoma .e 3046 to 3803 1 to 754       754/754
(100 %)
11 diff
(98.6 %id)
EB388864 eye, optic nerve .e 3057 to 3764 1 to 708       708/708
(100 %)
2 diff
(99.8 %id)
BC021016 Placenta, choriocarcinoma .e 3106 to 4360 1 to 1255   available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1255/1255
(100 %)
2 diff
(99.9 %id)
BE410919 choriocarcinoma, placenta .e 3107 to 3797 28 to 712   available from MGC,   685/774
(88 %)
12 diff
(98.5 %id)
BE409790 choriocarcinoma, placenta .e 3117 to 3777 38 to 690       653/751
(86 %)
22 diff
(97.1 %id)
CB266308 adipose .e 3198 to 3530 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
CN337675 embryonic stem cells, DMSO-treated H9 cellline .e 3257 to 3951 1 to 698       698/698
(100 %)
2 diff
(99.8 %id)
BM704888 eye, RPE and Choroid .e 3279 to 3716 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BC019585 Brain, anaplastic oligodendroglioma with1p/19q loss .e 3291 to 4361 13 to 1083   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1071/1083
(98 %)
9 diff
(99.2 %id)
BF528867 anaplastic oligodendroglioma with 1p/19qloss, brain .e 3291 to 3795 13 to 510   available from MGC,   498/510
(97 %)
6 diff
(98.9 %id)
BF528682 anaplastic oligodendroglioma with 1p/19qloss, brain .e 3291 to 4102 12 to 815       804/900
(89 %)
6 diff
(99.4 %id)
TI_159723978   .e 3452 to 4360 975 to 78   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 898/1003
(89 %)
16 diff
(98.5 %id)
BQ640489 eye, retina .e 3465 to 4036 1 to 572       572/572
(100 %)
0 diff
(100 %id)
TI_149302116   .e 3484 to 4361 953 to 85   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 869/970
(89 %)
15 diff
(98.5 %id)
CA944662 Human Lung Epithelial cells, lung .e 3526 to 4360 848 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 832/832
(100 %)
3 diff
(99.7 %id)
TI_154097129   .e 3557 to 4358 876 to 91   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 786/796
(98 %)
22 diff
(97.3 %id)
TI_1948152486   .e 3647 to 4133 123 to 609       487/511
(95 %)
6 diff
(98.9 %id)
TI_1948152618   .e 3647 to 4217 119 to 691       573/1349
(42 %)
20 diff
(98.6 %id)
TI_1948152769   .e 3647 to 4135 128 to 617       490/1333
(36 %)
9 diff
(99.4 %id)
CV029834 mixed .e 3652 to 3724 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
TI_1948152898   .e 3662 to 3953 135 to 435   fully sequenced,   301/435
(69 %)
9 diff
(98.0 %id)
BF528066 anaplastic oligodendroglioma with 1p/19qloss, brain .e 3669 to 4360 1 to 694       694/708
(98 %)
12 diff
(98.4 %id)
BM678586 eye, fetal eye .e 3694 to 4361 686 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 668/668
(100 %)
0 diff
(100 %id)
BF528547 anaplastic oligodendroglioma with 1p/19qloss, brain .e 3749 to 4041 493 to 785       678/789
(85 %)
40 diff
(95.0 %id)
BU741593 eye, fetal eye .e 3760 to 4363 622 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 604/604
(100 %)
2 diff
(99.7 %id)
BM980372 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 3770 to 4361 610 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 592/592
(100 %)
0 diff
(100 %id)
BF963114 nervous_normal .e 3781 to 3941 16 to 177       162/177
(91 %)
10 diff
(94.4 %id)
BF062925 colon, colon tumor, RER+ .e 3802 to 4349 577 to 30   AAA   548/559
(98 %)
0 diff
(100 %id)
H98977 melanocyte .e 3841 to 4363 522 to 1       522/522
(100 %)
11 diff
(97.9 %id)
AA335644 epididymis .e 3852 to 4061 1 to 209       209/209
(100 %)
3 diff
(98.6 %id)
AW082356 pooled .e 3859 to 4360 502 to 1       502/502
(100 %)
0 diff
(100 %id)
BG251754 adenocarcinoma, cell line, Liver .e 3863 to 4362 1 to 501   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 501/501
(100 %)
1 diff
(99.9 %id)
CR744234   .e 3884 to 4360 490 to 15   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 476/476
(100 %)
1 diff
(99.8 %id)
BU736846 eye, RPE and Choroid .e 3889 to 4360 490 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
AA677688 liver and spleen .e 3890 to 4363 471 to 1       471/471
(100 %)
8 diff
(98.4 %id)
AI762160 B-cell, chronic lymphotic leukemia .e 3899 to 4360 470 to 8       463/470
(98 %)
0 diff
(100 %id)
AI568402 B-cell, chronic lymphotic leukemia .e 3902 to 4362 464 to 4       461/464
(99 %)
0 diff
(100 %id)
TI_1948152899   .e 3923 to 4224 422 to 121   fully sequenced,   302/422
(71 %)
5 diff
(98.9 %id)
AI554518 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 3945 to 4160 216 to 1       216/216
(100 %)
0 diff
(100 %id)
CA440594 Chondrosarcoma, Left Pubic Bone .e 3948 to 4358 427 to 17   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 411/411
(100 %)
0 diff
(100 %id)
AI217620 heart .e 3976 to 4360 387 to 3       385/387
(99 %)
0 diff
(100 %id)
AI281666 esophagus, squamous cell carcinoma .e 3986 to 4360 380 to 6       375/380
(98 %)
0 diff
(100 %id)
R50856 whole brain .e 4005 to 4361 375 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 357/357
(100 %)
7 diff
(98.1 %id)
AA969114 pooled .e 4009 to 4359 350 to 3       348/350
(99 %)
0 diff
(100 %id)
AW129492 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 4012 to 4360 369 to 21   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 349/349
(100 %)
12 diff
(96.6 %id)
AW137279   .e 4030 to 4360 346 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 331/331
(100 %)
1 diff
(99.7 %id)
AI763068 2 pooled tumors (clear cell type), Kidney .e 4048 to 4356 320 to 12       309/320
(96 %)
0 diff
(100 %id)
AW469082 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 4056 to 4160 105 to 1       105/107
(98 %)
2 diff
(98.2 %id)
R40661 whole brain .e 4057 to 4363 316 to 10       307/316
(97 %)
0 diff
(100 %id)
AI193488 lung .e 4059 to 4362 302 to 1       302/305
(99 %)
4 diff
(98.7 %id)
H23434 whole brain .e 4076 to 4360 293 to 9       285/293
(97 %)
0 diff
(100 %id)
AI205732   .e 4082 to 4361 284 to 5       280/284
(98 %)
0 diff
(100 %id)
AA995179 Kidney .e 4090 to 4361 272 to 1       272/287
(94 %)
6 diff
(98.0 %id)
EC486551 Prostate .e 4110 to 4207 19 to 116       98/116
(84 %)
6 diff
(94.9 %id)
T09489   .e 4145 to 4361 217 to 1       217/217
(100 %)
0 diff
(100 %id)
DV459535 cochlea, ear .e 4170 to 4291 8 to 129       122/129
(94 %)
6 diff
(95.4 %id)
BU734337 eye, RPE and Choroid .e 4183 to 4360 196 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 178/178
(100 %)
0 diff
(100 %id)
AW198194 adenocarcinoma, Pancreas .e 4190 to 4361 184 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 173/173
(100 %)
1 diff
(99.5 %id)
CB997033 placenta, pre-eclamptic placenta .f 1 to 625 18 to 651   tiling clone,   634/965
(65 %)
21 diff
(97.9 %id)
CB996539 placenta, pre-eclamptic placenta .f 1 to 750 18 to 780   tiling clone,   763/813
(93 %)
36 diff
(95.6 %id)
CD110257 placenta, pre-eclamptic placenta .f 1 to 825 18 to 853 R168K G170R P215S G225R L226S ... tiling clone,   836/860
(97 %)
28 diff
(96.8 %id)
CB995343 placenta, pre-eclamptic placenta .f 1 to 736 19 to 767   tiling clone,   749/915
(81 %)
25 diff
(97.3 %id)
CB993376 placenta, pre-eclamptic placenta .f 1 to 638 19 to 654   tiling clone,   636/687
(92 %)
15 diff
(97.9 %id)
H92365 eye, retina .g 1 to 286 1 to 286   tiling clone,   286/286
(100 %)
1 diff
(99.7 %id)
AA352877   .g 208 to 531 1 to 325   tiling clone,   325/325
(100 %)
2 diff
(99.4 %id)
AW954188   .g 209 to 807 1 to 597       597/603
(99 %)
23 diff
(96.2 %id)
U20896 melanoma .g 278 to 2096 1 to 1821 P13H L14P E15W E16K L17N ... tiling clone,   1821/1821
(100 %)
4 diff
(99.8 %id)
TI_153989662   .g 422 to 960 87 to 630     Submitted on the opposite strand 544/632
(86 %)
42 diff
(93.4 %id)
BQ025702 placenta .g 423 to 864 1 to 442   AAA Submitted on the opposite strand 442/442
(100 %)
2 diff
(99.6 %id)
BU727557 eye, optic nerve .g 423 to 884 1 to 462   fully sequenced, Submitted on the opposite strand 462/462
(100 %)
2 diff
(99.6 %id)
AW139524   .g 424 to 818 1 to 396   AAA Submitted on the opposite strand 396/396
(100 %)
5 diff
(98.8 %id)
AW205680   .g 424 to 717 1 to 294   AAA Submitted on the opposite strand 294/294
(100 %)
0 diff
(100 %id)
BM853210 Ascites, stomach .g 424 to 744 34 to 354       321/354
(90 %)
6 diff
(98.4 %id)
BE669475 carcinoid, lung .g 435 to 937 1 to 503     Submitted on the opposite strand 503/503
(100 %)
0 diff
(100 %id)
BE464730 carcinoid, lung .g 438 to 877 1 to 440     Submitted on the opposite strand 440/440
(100 %)
1 diff
(99.8 %id)
BE502869 carcinoid, lung .g 438 to 910 1 to 473     Submitted on the opposite strand 473/479
(98 %)
1 diff
(99.8 %id)
BF432906 carcinoid, lung .g 438 to 906 1 to 469     Submitted on the opposite strand 469/469
(100 %)
6 diff
(98.8 %id)
BF940515 fibrotheoma, ovary .g 439 to 756 1 to 318     Submitted on the opposite strand 318/318
(100 %)
0 diff
(100 %id)
AI076530 liver and spleen .g 440 to 841 1 to 402     Submitted on the opposite strand 402/402
(100 %)
1 diff
(99.8 %id)
N21175 melanocyte .g 441 to 879 1 to 439     Submitted on the opposite strand 439/439
(100 %)
1 diff
(99.8 %id)
N51475 multiple sclerosis lesions .g 441 to 918 1 to 481     Submitted on the opposite strand 481/481
(100 %)
4 diff
(99.2 %id)
AA953986 pooled .g 441 to 746 1 to 306     Submitted on the opposite strand 306/306
(100 %)
1 diff
(99.7 %id)
AI076664 liver and spleen .g 441 to 846 1 to 406     Submitted on the opposite strand 406/406
(100 %)
1 diff
(99.8 %id)
AI248813 liver and spleen .g 441 to 881 1 to 441     Submitted on the opposite strand 441/441
(100 %)
1 diff
(99.8 %id)
AI860326 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .g 441 to 945 1 to 505     Submitted on the opposite strand 505/505
(100 %)
1 diff
(99.9 %id)
FN141641 breast carcinoma .g 464 to 577 113 to 1     Submitted on the opposite strand 113/113
(100 %)
1 diff
(99.2 %id)
TI_149283436   .g 523 to 1206 766 to 83   AAA   684/684
(100 %)
0 diff
(100 %id)
BQ184135 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 553 to 1206 672 to 19   AAA   654/672
(97 %)
0 diff
(100 %id)
TI_151809399   .g 553 to 1203 78 to 728   AAA   651/655
(99 %)
4 diff
(99.4 %id)
CA314983 Human Lung Epithelial cells, lung .g 560 to 1225 665 to 1       665/665
(100 %)
2 diff
(99.7 %id)
BM984070 lung, Primary Lung Epithelial Cells .g 562 to 1206 663 to 19   AAA   645/645
(100 %)
0 diff
(100 %id)
AA143178 uterus .g 578 to 816 1 to 240   fully sequenced,   240/240
(100 %)
1 diff
(99.6 %id)
BX113678 melanocyte .g 643 to 1226 585 to 1       585/585
(100 %)
4 diff
(99.4 %id)
AA291374 ovarian tumor, ovary .g 722 to 1210 1 to 489   fully sequenced,   489/489
(100 %)
0 diff
(100 %id)
W69258 heart .g 739 to 1205 477 to 1     Submitted on the opposite strand 477/484
(98 %)
11 diff
(97.8 %id)
N29137 melanocyte .g 740 to 1228 498 to 6     Submitted on the opposite strand 493/499
(98 %)
0 diff
(100 %id)
CB162272 Liver .g 741 to 1227 512 to 24     Submitted on the opposite strand 489/512
(95 %)
0 diff
(100 %id)
BG149731 carcinoid, lung .g 742 to 1217 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
AW514373 pooled .g 757 to 1212 456 to 1       456/456
(100 %)
0 diff
(100 %id)
DB547420 hippocampus .g 765 to 1212 1 to 448     Submitted on the opposite strand 448/448
(100 %)
0 diff
(100 %id)
AA405883 ovarian tumor, ovary .g 766 to 1207 1 to 441   fully sequenced,   441/441
(100 %)
4 diff
(99.1 %id)
AA402976 ovarian tumor, ovary .g 775 to 1207 434 to 1     Submitted on the opposite strand 434/434
(100 %)
1 diff
(99.8 %id)
FN122166 breast carcinoma .g 783 to 857 1 to 75       75/75
(100 %)
0 diff
(100 %id)
AA464138 ovarian tumor, ovary .g 784 to 1213 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AA143060 uterus .g 786 to 1212 418 to 1   fully sequenced,   418/418
(100 %)
1 diff
(99.8 %id)
AI302147 carcinoid, lung .g 795 to 1223 429 to 1       429/429
(100 %)
0 diff
(100 %id)
CN293076 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 806 to 1216 411 to 1     Submitted on the opposite strand 411/413
(99 %)
0 diff
(100 %id)
BG413461 pooled .g 819 to 1213 395 to 1       395/395
(100 %)
0 diff
(100 %id)
BM687096 eye, optic nerve .g 854 to 1235 386 to 5   fully sequenced, Submitted on the opposite strand 382/386
(98 %)
3 diff
(99.3 %id)
AA405192 ovarian tumor, ovary .g 886 to 1213 328 to 1   fully sequenced,   328/328
(100 %)
1 diff
(99.7 %id)
BE502320 pooled germ cell tumors .g 890 to 1212 323 to 1       323/368
(87 %)
0 diff
(100 %id)
BQ021895 placenta .g 894 to 1212 336 to 18   AAA   319/319
(100 %)
2 diff
(99.4 %id)
AA548070 adrenal adenoma, adrenal gland .g 947 to 1211 266 to 1       266/266
(100 %)
1 diff
(99.7 %id)
AW514516 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 984 to 1210 230 to 3       228/230
(99 %)
0 diff
(100 %id)
AI289509 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 990 to 1212 223 to 1       223/223
(100 %)
0 diff
(100 %id)
N53616 multiple sclerosis lesions .g 1033 to 1156 123 to 1     Submitted on the opposite strand 123/123
(100 %)
1 diff
(99.2 %id)
AA403301 ovarian tumor, ovary .g 1082 to 1213 132 to 1   fully sequenced,   132/132
(100 %)
0 diff
(100 %id)
BQ441835 melanotic melanoma, skin .h 1 to 518 1 to 525 G146S N150E R151P D152R F153L ... tiling clone,   525/1027
(51 %)
14 diff
(98.7 %id)
DB478752 hippocampus .h 212 to 918 1 to 706   tiling clone,   706/715
(98 %)
10 diff
(98.7 %id)
BX510088   .h 269 to 853 1 to 585   tiling clone,   585/585
(100 %)
9 diff
(98.5 %id)
CV569853 cornea, eye .h 277 to 860 1 to 586   tiling clone,   586/586
(100 %)
3 diff
(99.5 %id)
BY797622 eye .h 301 to 836 1 to 536   tiling clone,   536/536
(100 %)
0 diff
(100 %id)
BF947864 nervous_normal .h 303 to 567 16 to 281       266/283
(93 %)
16 diff
(94.4 %id)
AA745242 germinal center B cell .h 319 to 760 1 to 440     Submitted on the opposite strand 440/440
(100 %)
2 diff
(99.6 %id)
AA732575 germinal center B cell .h 353 to 796 1 to 442     Submitted on the opposite strand 442/442
(100 %)
4 diff
(99.1 %id)
BE178189 head_neck .h 357 to 647 28 to 317       290/324
(89 %)
9 diff
(97.3 %id)
BE178335 head_neck .h 361 to 647 18 to 301       284/308
(92 %)
8 diff
(97.5 %id)
BE172779 head_neck .h 444 to 554 114 to 4     Submitted on the opposite strand 111/114
(97 %)
0 diff
(100 %id)
DA292702 hippocampus .i 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
BG394116 eye, retinoblastoma .i 274 to 980 1 to 702       702/976
(71 %)
15 diff
(98.5 %id)
BC001806 Eye, retinoblastoma .i 275 to 2239 1 to 1965   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 1965/1965
(100 %)
4 diff
(99.8 %id)
DA868964 Prostate .j-u 1 to 539 2 to 540   tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
BI770159 pooled lung and spleen .j-u 13 to 943 1 to 932 V4L G8V G9A L10C R11A ... tiling clone,   932/932
(100 %)
27 diff
(97.2 %id)
TI_57178221   .j-u 13 to 943 28 to 959 V4L G8V G9A L10C R11A ...     932/959
(97 %)
6 diff
(99.4 %id)
TI_149285820   .j-u 841 to 1549 795 to 87   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 709/711
(99 %)
0 diff
(100 %id)
DW414001 Liver .j-u 902 to 1212 8 to 318   tiling clone,   311/318
(97 %)
9 diff
(97.2 %id)
BM971689 lung .j-u 985 to 1549 585 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 565/567
(99 %)
0 diff
(100 %id)
AL705859 human skeletal muscle .k 1 to 729 1 to 730   tiling clone,   730/730
(100 %)
8 diff
(99.0 %id)
DA122760 cerebellum .k 128 to 636 2 to 510   tiling clone, capped   509/509
(100 %)
5 diff
(99.1 %id)
CN361007 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 488 to 1103 1 to 616   tiling clone,   616/616
(100 %)
7 diff
(98.9 %id)
AL134280 brain .k 516 to 886 1 to 371       371/371
(100 %)
4 diff
(99.0 %id)
DN991328 brain, whole brain .k 586 to 1179 1 to 595 exact     595/595
(100 %)
7 diff
(98.9 %id)
CB048359 Prostate .k 601 to 938 28 to 365   fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 338/365
(92 %)
5 diff
(98.7 %id)
BQ187190 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 735 to 1474 1 to 740 exact fully sequenced, Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 740/740
(100 %)
2 diff
(99.8 %id)
TI_151734253   .k 738 to 1493 867 to 116 L16X I40X AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 752/922
(81 %)
8 diff
(99.2 %id)
CB048358 Prostate .k 908 to 1490 620 to 38   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 583/583
(100 %)
2 diff
(99.7 %id)
BQ028171 mixed .k 971 to 1490 538 to 19   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 520/539
(96 %)
0 diff
(100 %id)
TI_2194643750   .k 975 to 1637 806 to 144       663/808
(82 %)
0 diff
(100 %id)
AL360266   .k 994 to 2974 1 to 1981   tiling clone,   1981/1990
(99 %)
5 diff
(99.8 %id)
AI660669 colon, colonic mucosa from 5 ulcerative colitispatients .k 1019 to 1490 483 to 12   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 472/472
(100 %)
1 diff
(99.8 %id)
CA448895 Chondrosarcoma, Left Pelvis .k 1031 to 1493 478 to 16   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 463/463
(100 %)
5 diff
(99.0 %id)
BG723598 testis .k 1034 to 1762 1 to 728   tiling clone,   728/728
(100 %)
5 diff
(99.4 %id)
AV739184 cord Blood .k 1039 to 1491 41 to 485   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 445/487
(91 %)
15 diff
(97.0 %id)
DB447870.
matches multiple genes
testis .k 1039 to 1469 1 to 431     also hits gene tirori 431/431
(100 %)
0 diff
(100 %id)
AV736187 cord Blood .k 1042 to 1448 44 to 429       386/435
(88 %)
24 diff
(94.5 %id)
BQ931715 eye, normal pigmented retinal epithelium .k 1042 to 1490 16 to 463   AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 448/463
(96 %)
7 diff
(98.5 %id)
CK300535 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 1149 to 1493 360 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 345/345
(100 %)
1 diff
(99.8 %id)
BX508411   .l 1 to 221 156 to 375   tiling clone,   220/375
(58 %)
6 diff
(98.4 %id)
DB465676 hippocampus .l 62 to 486 1 to 423   tiling clone,   423/423
(100 %)
8 diff
(98.2 %id)
BE895886 melanotic melanoma, skin .m 1 to 786 1 to 782 exact tiling clone,   782/863
(90 %)
23 diff
(97.4 %id)
AW949932   .n 1 to 623 5 to 632 I50N K51* tiling clone,   632/634
(99 %)
25 diff
(96.1 %id)
AA937607 adenocarcinoma, colon .o 1 to 379 1 to 377 P2D L3R R4C P5A P6S ... tiling clone, Submitted on the opposite strand 377/377
(100 %)
8 diff
(97.9 %id)
W69171 heart .o 21 to 484 22 to 486   tiling clone, Submitted on the opposite strand 465/487
(95 %)
15 diff
(97.0 %id)
AA402033 ovarian tumor, ovary .o 43 to 434 1 to 391     Submitted on the opposite strand 391/391
(100 %)
5 diff
(98.8 %id)
DA726126   .p 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
3 diff
(99.5 %id)
CR617170 T cells (Jurkat cell line) Cot10-normalized .q 1 to 1505 2 to 1506 exact tiling clone,   1506/1506
(100 %)
0 diff
(100 %id)
BX340943   .q 1 to 775 2 to 776 exact fully sequenced,   776/776
(100 %)
2 diff
(99.8 %id)
BI090581 cervix .q 223 to 960 1 to 746       746/746
(100 %)
17 diff
(97.8 %id)
BM477708 leiomyosarcoma, uterus .q 278 to 1159 908 to 18     Submitted on the opposite strand 891/1052
(84 %)
0 diff
(100 %id)
BX340942   .q 745 to 1505 760 to 1   fully sequenced,   760/760
(100 %)
8 diff
(99.0 %id)
BF059122 pooled germ cell tumors .q 997 to 1536 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AW300750 colon, moderately differentiated adenocarcinoma .q 1119 to 1528 410 to 1       410/410
(100 %)
0 diff
(100 %id)
DA960883 Spleen .q 1471 to 2017 2 to 548   tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
BQ881613 dorsal root ganglia .r-u 1 to 793 6 to 808 exact tiling clone,   803/890
(90 %)
13 diff
(98.6 %id)
DB084378 testis .s-u 1 to 554 2 to 555 exact tiling clone, capped   554/554
(100 %)
0 diff
(100 %id)
W15556 lung .s-u 51 to 516 1 to 474       474/479
(98 %)
14 diff
(97.1 %id)
N80787 lung .s-u 317 to 770 463 to 1   tiling clone,   463/463
(100 %)
13 diff
(97.2 %id)
AI673110 colon, colonic mucosa from 3 patients with Crohn'sdisease .s-u 593 to 771 179 to 1   tiling clone,   179/179
(100 %)
0 diff
(100 %id)
AV648386 corresponding non cancerous liver tissue .t 1 to 717 1 to 715 exact tiling clone, Submitted on the opposite strand 715/724
(98 %)
11 diff
(98.5 %id)
DA741565   .u 1 to 506 2 to 507   tiling clone, capped   506/507
(99 %)
1 diff
(99.9 %id)
DA234916 brain .u 2 to 597 2 to 594   tiling clone, capped   593/593
(100 %)
5 diff
(99.2 %id)
DB151380 thymus .u 9 to 572 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DB095066 testis .va 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DA382180 thalamus .vb 1 to 499 2 to 501 exact tiling clone, capped   500/500
(100 %)
2 diff
(99.6 %id)
BF378794 uterus .vc-u 1 to 394 398 to 5 exact tiling clone,   394/398
(98 %)
0 diff
(100 %id)
BF378805 uterus .vc-u 4 to 379 381 to 6 exact     376/381
(98 %)
0 diff
(100 %id)
DA867461 Prostate .vd-u 1 to 343 2 to 345 L15F E16R T17D E18R F19I ... tiling clone, capped   344/344
(100 %)
8 diff
(97.7 %id)
H89953 eye, retina Gene MUM1, variant not shown         This clone was ignored    
H92004 eye, retina Gene MUM1, variant not shown         This clone was ignored    
DN993266 brain, whole brain Gene MUM1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q, .r-u, .s-u, .t, .u, .va, .vb, .vc-u, .vd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC